WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study

BACKGROUND: Cutaneous leishmaniasis (CL) is a disfiguring disease that confronts clinicians with a quandary: leave patients untreated or engage in a complex or toxic treatment. Topical treatment of CL offers a practical and safe option. Accordingly, the treatment of CL with WR279,396, a formulation...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Ben Salah, Afif, Buffet, Pierre A., Morizot, Gloria, Ben Massoud, Nathalie, Zâatour, Amor, Ben Alaya, Nissaf, Haj Hamida, Nabil Bel, Ahmadi, Zaher El, Downs, Matthew T., Smith, Philip L., Dellagi, Koussay, Grögl, Max
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2009
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2673687/
https://ncbi.nlm.nih.gov/pubmed/19415122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0000432
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares